Free Trial

Crescent Capital BDC (CCAP) Competitors

$18.79
+0.13 (+0.70%)
(As of 06/7/2024 ET)

CCAP vs. LU, UPST, PWP, IREN, CIFR, SII, ML, BITF, CORZ, and HUT

Should you be buying Crescent Capital BDC stock or one of its competitors? The main competitors of Crescent Capital BDC include Lufax (LU), Upstart (UPST), Perella Weinberg Partners (PWP), Iris Energy (IREN), Cipher Mining (CIFR), Sprott (SII), MoneyLion (ML), Bitfarms (BITF), Core Scientific (CORZ), and Hut 8 (HUT). These companies are all part of the "nondepository credit institutions" industry.

Crescent Capital BDC vs.

Lufax (NYSE:LU) and Crescent Capital BDC (NASDAQ:CCAP) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations.

Lufax has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500. Comparatively, Crescent Capital BDC has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500.

Lufax pays an annual dividend of $0.25 per share and has a dividend yield of 10.9%. Crescent Capital BDC pays an annual dividend of $1.64 per share and has a dividend yield of 8.7%. Lufax pays out -178.6% of its earnings in the form of a dividend. Crescent Capital BDC pays out 58.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Lufax is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Lufax had 9 more articles in the media than Crescent Capital BDC. MarketBeat recorded 13 mentions for Lufax and 4 mentions for Crescent Capital BDC. Lufax's average media sentiment score of 0.49 beat Crescent Capital BDC's score of 0.25 indicating that Crescent Capital BDC is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Lufax
3 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Crescent Capital BDC
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Lufax has higher revenue and earnings than Crescent Capital BDC. Lufax is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lufax$4.82B0.27$125.31M-$0.14-16.32
Crescent Capital BDC$184.13M3.78$83.84M$2.816.69

Crescent Capital BDC has a net margin of 53.32% compared to Crescent Capital BDC's net margin of -2.17%. Lufax's return on equity of 11.99% beat Crescent Capital BDC's return on equity.

Company Net Margins Return on Equity Return on Assets
Lufax-2.17% -0.72% -0.27%
Crescent Capital BDC 53.32%11.99%5.44%

Lufax presently has a consensus price target of $5.68, suggesting a potential upside of 148.58%. Crescent Capital BDC has a consensus price target of $18.75, suggesting a potential downside of 0.21%. Given Crescent Capital BDC's higher possible upside, research analysts clearly believe Lufax is more favorable than Crescent Capital BDC.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lufax
1 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.75
Crescent Capital BDC
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

69.1% of Lufax shares are held by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are held by institutional investors. 1.0% of Crescent Capital BDC shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Crescent Capital BDC received 7 more outperform votes than Lufax when rated by MarketBeat users. Likewise, 55.56% of users gave Crescent Capital BDC an outperform vote while only 43.40% of users gave Lufax an outperform vote.

CompanyUnderperformOutperform
LufaxOutperform Votes
23
43.40%
Underperform Votes
30
56.60%
Crescent Capital BDCOutperform Votes
30
55.56%
Underperform Votes
24
44.44%

Summary

Crescent Capital BDC beats Lufax on 12 of the 20 factors compared between the two stocks.

Get Crescent Capital BDC News Delivered to You Automatically

Sign up to receive the latest news and ratings for CCAP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CCAP vs. The Competition

MetricCrescent Capital BDCNondepository credit institutions IndustryFinance SectorNASDAQ Exchange
Market Cap$696.36M$6.44B$9.42B$8.20B
Dividend Yield8.93%5.51%6.63%4.04%
P/E Ratio6.697.6056.4114.65
Price / Sales3.787.563,256.3778.07
Price / Cash8.7934.4115.7131.17
Price / Book0.942.072.494.32
Net Income$83.84M$441.59M$1.01B$216.21M
7 Day Performance3.58%3.95%-0.74%-1.43%
1 Month Performance6.58%8.03%-0.14%-0.59%
1 Year Performance34.02%54.66%12.26%3.58%

Crescent Capital BDC Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LU
Lufax
4.4772 of 5 stars
$4.47
-0.2%
$6.40
+43.2%
-63.7%$2.56B$4.82B-31.9336,215Ex-Dividend
UPST
Upstart
2.1637 of 5 stars
$24.22
-2.0%
$26.78
+10.6%
-13.8%$2.13B$513.56M-11.761,388Analyst Upgrade
Insider Selling
News Coverage
Gap Down
PWP
Perella Weinberg Partners
1.3748 of 5 stars
$15.10
-2.2%
$16.50
+9.3%
+73.4%$1.42B$648.65M-8.12650Positive News
IREN
Iris Energy
3.4024 of 5 stars
$8.80
+13.0%
$12.50
+42.0%
+209.7%$1.29B$75.51M0.00100Analyst Forecast
Options Volume
News Coverage
CIFR
Cipher Mining
2.0774 of 5 stars
$3.75
+1.1%
$5.50
+46.7%
+73.0%$1.16B$126.84M62.5135Analyst Forecast
Insider Selling
Options Volume
News Coverage
SII
Sprott
0 of 5 stars
$44.24
-1.4%
N/A+29.1%$1.14B$169.02M24.72129Negative News
ML
MoneyLion
0.5192 of 5 stars
$95.56
-3.0%
$78.60
-17.7%
+624.7%$1.01B$423.43M-32.95600Gap Up
BITF
Bitfarms
2.465 of 5 stars
$2.36
+5.4%
$3.72
+57.5%
+114.3%$924.65M$146.37M-6.21170Analyst Forecast
Analyst Revision
CORZ
Core Scientific
0.3606 of 5 stars
$4.90
+3.2%
$7.17
+46.3%
+2,003.3%$871.14M$561.04M0.00286Analyst Forecast
Options Volume
News Coverage
HUT
Hut 8
2.0955 of 5 stars
$9.17
+5.5%
$12.25
+33.6%
+391.4%$828.88M$115.90M0.00219Analyst Forecast

Related Companies and Tools

This page (NASDAQ:CCAP) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners